article thumbnail

Book: Build the Fort: The Startup Community Builder’s Field Guide

Feld Thoughts

Chris Heivly released Build the Fort: The Startup Community Builder’s Field Guide. I encourage you to get Chris’s book if you are a startup community builder or are interested in startup communities. In our conversation with Chris, we proposed that he join Techstars to work on this together.

Community 117
article thumbnail

5 Cities for Ambitious Women in Business in 2020 and Beyond

Austin Startup

Raleigh, North Carolina Following closely in second is North Carolina’s Raleigh, thanks to a solid all-round performance. Raleigh’s economic growth (56% in the 2010s) has been noticed by the wider population. With a greater economy brings more job opportunities in the future. city over the next ten years.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Austin’s secret sauce… it’s the WHY

Austin Startup

After an exhaustive search, they narrowed it down to three finalist cities: Austin, Boston and Raleigh. When the Army Futures Command was searching for the location to launch their new headquarters, there were also focused on talent… but they knew they didn’t want to be in Silicon Valley. Why did Austin win out?

article thumbnail

MANAGING DIRECTOR OF TECHSTARS AUSTIN

Austin Startup

The panel will take questions and give stories and advice on startup sales from their vast wealth of experience in the entrepreneurial world. The W3 Method equips startups with the tools to articulate their strategy with their team, company, investors and customers. What are they buying? Why do they buy?

Austin 48
article thumbnail

Bio Roundup: Trump, Gottlieb, Gene Therapy Prices, IPO Hopes & More

Austin Startup

Two other big questions we raised immediately became topics of conversation this week, thanks to Spark Therapeutics, which set the price for its gene therapy—the first ever approved in the U.S.—at president and what it means for the biopharmaceutical business, a frequent target of his scattershot rants. —at $850,000.

IPO 48